Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea.

Lee CG, Lim YJ, Park SJ, Jang BI, Choi SR, Kim JK, Kim YT, Cho JY, Yang CH, Chun HJ, Song SY; Neuroendocrine tumor study group.

BMC Cancer. 2014 Aug 7;14:569. doi: 10.1186/1471-2407-14-569.

2.

Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer.

Yoshii T, Ohkawa S, Tamai S, Kameda Y.

Dis Esophagus. 2013 Jul;26(5):496-502. doi: 10.1111/j.1442-2050.2012.01370.x. Epub 2012 Jun 7.

PMID:
22676622
3.

Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes.

Hallet J, Law CH, Cukier M, Saskin R, Liu N, Singh S.

Cancer. 2015 Feb 15;121(4):589-97. doi: 10.1002/cncr.29099. Epub 2014 Oct 13.

4.

Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan.

Ito T, Sasano H, Tanaka M, Osamura RY, Sasaki I, Kimura W, Takano K, Obara T, Ishibashi M, Nakao K, Doi R, Shimatsu A, Nishida T, Komoto I, Hirata Y, Nakamura K, Igarashi H, Jensen RT, Wiedenmann B, Imamura M.

J Gastroenterol. 2010 Feb;45(2):234-43. doi: 10.1007/s00535-009-0194-8.

PMID:
20058030
5.

Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study.

Gastrointestinal Pathology Study Group of Korean Society of Pathologists, Cho MY, Kim JM, Sohn JH, Kim MJ, Kim KM, Kim WH, Kim H, Kook MC, Park do Y, Lee JH, Chang H, Jung ES, Kim HK, Jin SY, Choi JH, Gu MJ, Kim S, Kang MS, Cho CH, Park MI, Kang YK, Kim YW, Yoon SO, Bae HI, Joo M, Moon WS, Kang DY, Chang SJ.

Cancer Res Treat. 2012 Sep;44(3):157-65. doi: 10.4143/crt.2012.44.3.157. Epub 2012 Sep 30.

6.

Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors.

Tsukamoto S, Fujita S, Yamaguchi T, Yamamoto S, Akasu T, Moriya Y, Taniguchi H, Shimoda T.

Int J Colorectal Dis. 2008 Nov;23(11):1109-13. doi: 10.1007/s00384-008-0505-1. Epub 2008 Jul 2.

PMID:
18594844
7.

Endoscopic resection for gastrointestinal neuroendocrine tumors.

Boškoski I, Volkanovska A, Tringali A, Bove V, Familiari P, Perri V, Costamagna G.

Expert Rev Gastroenterol Hepatol. 2013 Aug;7(6):559-69. doi: 10.1586/17474124.2013.816117. Review.

PMID:
23985005
8.

Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study.

Zhang X, Ma L, Bao H, Zhang J, Wang Z, Gong P.

BMC Endocr Disord. 2014 Jul 8;14:54. doi: 10.1186/1472-6823-14-54.

9.

Resectability of primary gastroenteropancreatic neuroendocrine tumor as a prognostic factor for survival.

Medrano-Guzmán R, López-García SC, Torres-Vargas S, González-Rodríguez D, Alvarado-Cabrero I.

Cir Cir. 2011 Nov-Dec;79(6):498-504. English, Spanish.

PMID:
22169366
10.

A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma.

Taniyama Y, Nakamura T, Mitamura A, Teshima J, Katsura K, Abe S, Nakano T, Kamei T, Miyata G, Ouchi N.

Ann Thorac Surg. 2013 Jun;95(6):1930-7. doi: 10.1016/j.athoracsur.2013.03.069. Epub 2013 May 1.

PMID:
23642437
11.

Neuroendocrine neoplasms of the jejunum: a heterogeneous group with distinctive proximal and distal subsets.

Chopin-Laly X, Walter T, Hervieu V, Poncet G, Adham M, Guibal A, Chayvialle JA, Lombard-Bohas C, Scoazec JY.

Virchows Arch. 2013 May;462(5):489-99. doi: 10.1007/s00428-013-1411-7. Epub 2013 Apr 12.

PMID:
23579432
12.

[Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].

Han JQ, Liu Q, Liang RX, Qu FS, Yan TX, Sun YH, Li XQ.

Zhonghua Zhong Liu Za Zhi. 2007 Jun;29(6):470-3. Chinese.

PMID:
17974287
13.

Non-L-cell immunophenotype and large tumor size in rectal neuroendocrine tumors are associated with aggressive clinical behavior and worse prognosis.

Kim JY, Kim KS, Kim KJ, Park IJ, Lee JL, Myung SJ, Park Y, Park YS, Yu CS, Kim JC, Yu E, Jang HJ, Hong SM.

Am J Surg Pathol. 2015 May;39(5):632-43. doi: 10.1097/PAS.0000000000000400.

PMID:
25724002
14.

Low-grade neuroendocrine tumors arising in intestinal adenomas: evidence for alterations in the adenomatous polyposis coli/β-catenin pathway.

Estrella JS, Taggart MW, Rashid A, Abraham SC.

Hum Pathol. 2014 Oct;45(10):2051-8. doi: 10.1016/j.humpath.2014.07.001. Epub 2014 Jul 24.

PMID:
25149552
15.

[Neuroendocrine tumors: analysis of 252 cases].

Chi YH, Jiang WC, Du F, Sun YK, Song Y, Yang L, Zhou AP, Wang JW.

Zhonghua Zhong Liu Za Zhi. 2013 Jan;35(1):67-70. doi: 10.3760/cma.j.issn.0253-3766.2013.01.015. Chinese.

PMID:
23648305
16.

[Neuroendocrine tumors of the stomach. Risk stratification and therapy].

Klöppel G, Scherübl H.

Pathologe. 2010 May;31(3):182-7. doi: 10.1007/s00292-009-1268-3. German.

PMID:
20306044
17.

Distal esophageal carcinomas in Chinese patients vary widely in histopathology, but adenocarcinomas remain rare.

Huang Q, Shi J, Sun Q, Fan X, Feng A, Wu H, Zhou Q, Yu C, Mashimo H, Lauwers GY.

Hum Pathol. 2012 Dec;43(12):2138-48. doi: 10.1016/j.humpath.2012.02.018. Epub 2012 Jun 1.

PMID:
22658274
18.

Surveillance strategy for rectal neuroendocrine tumors according to recurrence risk stratification.

Kim DH, Lee JH, Cha YJ, Park SJ, Cheon JH, Kim TI, Kim H, Kim WH, Hong SP.

Dig Dis Sci. 2014 Apr;59(4):850-6. doi: 10.1007/s10620-013-2972-7. Epub 2013 Dec 10.

PMID:
24323182
19.

Nonfunctioning neuroendocrine pancreatic tumors: our experience and management.

Nomura N, Fujii T, Kanazumi N, Takeda S, Nomoto S, Kasuya H, Sugimoto H, Yamada S, Nakao A.

J Hepatobiliary Pancreat Surg. 2009;16(5):639-47. doi: 10.1007/s00534-009-0099-1. Epub 2009 Apr 14.

PMID:
19365596
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk